Lv72
3740 积分 2023-05-29 加入
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
7天前
已完结
Comparison of Child-Pugh (CP) criteria and NCI organ dysfunction working group (NCI-ODWG) criteria for hepatic dysfunction (HD): Implications for chemotherapy dosing
1个月前
已关闭
New drug targets for hypertension: A literature review
2个月前
已完结
Revealing new therapeutic opportunities in hypertension through network-driven integrative genetic analysis and drug target prediction approach
2个月前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
4个月前
已完结
Trends in the drug target landscape for autoimmune diseases
4个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
